Login to Your Account

Pharma: Other News To Note

Tuesday, June 19, 2012
• Horizon Pharma Inc., of Deerfield, Ill., and Mallinckrodt LLC, the pharmaceuticals business of Covidien LLC, of Dublin, Ireland, signed a U.S. co-promotion agreement for Duexis (ibuprofen and famotidine) to relieve symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription